PURE Bioscience FY2025 net product sales $2.2M, net loss narrows to $2.4M from $3.4M

PURE BIOSCIENCE, INC.

Net product sales $2,198K for FY2025, up 12.4% from $1,955K in FY2024.
Net loss improved to ($2.4M) from ($3.4M); loss per share ($0.02) vs ($0.03).
Net cash used in operations ($2.0M) vs ($2.5M) in prior year.
Expanded distribution with Hydrite Chemical; launched membrane treatment for dairy/beverage.
Excluding share-based compensation, net loss was ($2.3M) vs ($3.1M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.